Cite
HARVARD Citation
Abu-Elyazeed, R. et al. (2018). Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study. Human vaccines & immunotherapeutics. 14 (11), pp. 2624-2631. [Online].